![PDF) Comparing responsiveness of the EQ-5D-5L, EQ-5D-3L and EQ VAS in stroke patients | Dominik Golicki - Academia.edu PDF) Comparing responsiveness of the EQ-5D-5L, EQ-5D-3L and EQ VAS in stroke patients | Dominik Golicki - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/44364020/mini_magick20190214-30068-j05p5v.png?1550192098)
PDF) Comparing responsiveness of the EQ-5D-5L, EQ-5D-3L and EQ VAS in stroke patients | Dominik Golicki - Academia.edu
Comparing the self-perceived quality of life of multimorbid patients and the general population using the EQ-5D-3L | PLOS ONE
Comparative responsiveness of the PROMIS-10 Global Health and EQ-5D questionnaires in patients undergoing total knee arthroplasty | Bone & Joint
![Health related QoL as measured by the EQ-5D-5L in PD patients after DBS therapy: Preliminary results from the Product Surveillance Registry - MDS Abstracts Health related QoL as measured by the EQ-5D-5L in PD patients after DBS therapy: Preliminary results from the Product Surveillance Registry - MDS Abstracts](https://www.mdsabstracts.org/wp-content/uploads/2017/05/0037-001137_001.jpg)
Health related QoL as measured by the EQ-5D-5L in PD patients after DBS therapy: Preliminary results from the Product Surveillance Registry - MDS Abstracts
![Why use the EQ-5D? What are the alternatives?. What are the alternatives for Direct valuation? Other VAS Time Trade-Off Standard Gamble Willingness to. - ppt download Why use the EQ-5D? What are the alternatives?. What are the alternatives for Direct valuation? Other VAS Time Trade-Off Standard Gamble Willingness to. - ppt download](https://images.slideplayer.com/33/7051951/slides/slide_3.jpg)
Why use the EQ-5D? What are the alternatives?. What are the alternatives for Direct valuation? Other VAS Time Trade-Off Standard Gamble Willingness to. - ppt download
![Fig. 1.6, [EQ VAS (EQ-5D-Y version).]. - Methods for Analysing and Reporting EQ-5D Data - NCBI Bookshelf Fig. 1.6, [EQ VAS (EQ-5D-Y version).]. - Methods for Analysing and Reporting EQ-5D Data - NCBI Bookshelf](https://www.ncbi.nlm.nih.gov/books/NBK565680/bin/456601_1_En_1_Fig6_HTML.jpg)
Fig. 1.6, [EQ VAS (EQ-5D-Y version).]. - Methods for Analysing and Reporting EQ-5D Data - NCBI Bookshelf
![Visual analog scale (VAS) used by the Euroqol Group. Source: Ref. [48] | Download Scientific Diagram Visual analog scale (VAS) used by the Euroqol Group. Source: Ref. [48] | Download Scientific Diagram](https://www.researchgate.net/publication/26874451/figure/fig1/AS:601768081776671@1520484099632/Visual-analog-scale-VAS-used-by-the-Euroqol-Group-Source-Ref-48.png)
Visual analog scale (VAS) used by the Euroqol Group. Source: Ref. [48] | Download Scientific Diagram
![PDF] Reliability and validity of the Thai version of EQ-5 D-5 L questionnaire on patients with chronic disease | Semantic Scholar PDF] Reliability and validity of the Thai version of EQ-5 D-5 L questionnaire on patients with chronic disease | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/de8012596c2577dd89a4200991e02054125bab6d/10-Table5-1.png)
PDF] Reliability and validity of the Thai version of EQ-5 D-5 L questionnaire on patients with chronic disease | Semantic Scholar
![A longitudinal validation of the EQ-5D-5L and EQ-VAS stand-alone component utilising the Oxford Hip Score in the Australian hip arthroplasty population | Journal of Patient-Reported Outcomes | Full Text A longitudinal validation of the EQ-5D-5L and EQ-VAS stand-alone component utilising the Oxford Hip Score in the Australian hip arthroplasty population | Journal of Patient-Reported Outcomes | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs41687-022-00482-7/MediaObjects/41687_2022_482_Fig1_HTML.png)
A longitudinal validation of the EQ-5D-5L and EQ-VAS stand-alone component utilising the Oxford Hip Score in the Australian hip arthroplasty population | Journal of Patient-Reported Outcomes | Full Text
Value calculator. EQ-5D, EuroQol-5D; EQ-VAS, EuroQol-Visual Analogue... | Download Scientific Diagram
![Experience-based health state valuation using the EQ VAS: a register-based study of the EQ-5D-3L among nine patient groups in Sweden | Health and Quality of Life Outcomes | Full Text Experience-based health state valuation using the EQ VAS: a register-based study of the EQ-5D-3L among nine patient groups in Sweden | Health and Quality of Life Outcomes | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12955-023-02115-z/MediaObjects/12955_2023_2115_Fig1_HTML.png)
Experience-based health state valuation using the EQ VAS: a register-based study of the EQ-5D-3L among nine patient groups in Sweden | Health and Quality of Life Outcomes | Full Text
![Fig. 1.4, [EQ VAS (current EQ-5D-5L and EQ-5D-3L version).]. - Methods for Analysing and Reporting EQ-5D Data - NCBI Bookshelf Fig. 1.4, [EQ VAS (current EQ-5D-5L and EQ-5D-3L version).]. - Methods for Analysing and Reporting EQ-5D Data - NCBI Bookshelf](https://www.ncbi.nlm.nih.gov/books/NBK565680/bin/456601_1_En_1_Fig4_HTML.jpg)
Fig. 1.4, [EQ VAS (current EQ-5D-5L and EQ-5D-3L version).]. - Methods for Analysing and Reporting EQ-5D Data - NCBI Bookshelf
![Psychometric properties of the EQ-5D-5L: a systematic review of the literature | Quality of Life Research Psychometric properties of the EQ-5D-5L: a systematic review of the literature | Quality of Life Research](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs11136-020-02688-y/MediaObjects/11136_2020_2688_Fig4c_HTML.png)
Psychometric properties of the EQ-5D-5L: a systematic review of the literature | Quality of Life Research
![Bulevirtide Improves Health-Related Quality of Life Measured by EQ-5D VAS in Patients With Chronic Hepatitis Delta: An Exploratory Analysis of a Phase 3 Trial at 48 Weeks Bulevirtide Improves Health-Related Quality of Life Measured by EQ-5D VAS in Patients With Chronic Hepatitis Delta: An Exploratory Analysis of a Phase 3 Trial at 48 Weeks](https://www.natap.org/2022/images/111522/111522-5/1115222.gif)
Bulevirtide Improves Health-Related Quality of Life Measured by EQ-5D VAS in Patients With Chronic Hepatitis Delta: An Exploratory Analysis of a Phase 3 Trial at 48 Weeks
![An Introduction to EQ-5D Instruments and Their Applications - Methods for Analysing and Reporting EQ-5D Data - NCBI Bookshelf An Introduction to EQ-5D Instruments and Their Applications - Methods for Analysing and Reporting EQ-5D Data - NCBI Bookshelf](https://www.ncbi.nlm.nih.gov/books/NBK565680/bin/456601_1_En_1_Figa_HTML.jpg)